EVOM™ STX Calibration Solution

The EVOM™ Auto High Throughput (HTS) Transepithiel Electrical Resistance (TEER) Measurement System with 24 and 96 transwell capability has a removable electrode array head. Different electrode arrays can be used with the same system to analyze a variety of 24 and 96 transwell HTS plates. 

EVOM™ Auto High Throughput (HTS) Transepithiel Electrical Resistance (TEER) Measurement System with 24 and 96 transwell capability can switch between different 24 and 96 HTS well plates by using matching electrode arrays and plate positioners. Here we demonstrate how to switch to a 24 transwell plate after using a 96 transwell plate. 

EVOM™ Auto High Throughput (HTS) Transepithiel Electrical Resistance (TEER) Measurement System with 24 and 96 transwell capability can switch between different 24 and 96 HTS transwell plates by using matching electrode arrays and plate positioner. Here we demonstrate how to install a well plate. 

EVOM™ Auto is WPI’s latest high throughput screening TEER measurement system with 24 and 96 HTS transwell plate measurement capability, and it offers easy options for switching between different plates. I will show you how to setup it up. The Interface Unit is the controller that establishes communication between the EVOM™ Auto software and the autosampler. 

Choosing a dependable lab equipment supplier is crucial for ensuring the quality, reliability, and timely delivery of the equipment you require.  When your research is on the line, you need a company you trust, a supplier with a proven track record and a service team to back you up. Here are a few important considerations when selecting a lab equipment supplier.

A new study by Altis Biosystems (Durham, NC) using the EVOM™ Auto is undergoing a peer review prior to publication. It addresses the challenge of predicting gastrointestinal toxicities (GITs) in drug development, which are common adverse events in clinical trials. ​ Traditional animal models fail to accurately replicate human GI physiology, leading to late detection of GITs. ​ Researchers Colleen Pike and James Levi (with their team) developed a high-throughput assay, a 2D human intestinal stem cell-derived model, which assesses cell proliferation, cell abundance, and barrier function to predict clinical diarrhea risk.

A new study by Altis Biosystems (Durham, NC) using the EVOM™ Auto is undergoing a peer review prior to publication. It addresses the challenge of predicting gastrointestinal toxicities (GITs) in drug development, which are common adverse events in clinical trials. ​ Traditional animal models fail to accurately replicate human GI physiology, leading to late detection of GITs. ​ Researchers Colleen Pike and James Levi (with their team) developed a high-throughput assay, a 2D human intestinal stem cell-derived model, which assesses cell proliferation, cell abundance, and barrier function to predict clinical diarrhea risk.